|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| |
ABSTRACT |
|---|
|
|
|---|
Heaves in horses shares many similarities with human asthma, including lower airway inflammation, reversible airway obstruction, and bronchial hyperresponsiveness. Extrinsic asthma is an allergic response to environmental allergens and a similar immunologic mechanism may be implicated in heaves. It is now recognized that a Th2 subset of CD4+ lymphocytes is associated with allergic diseases such as atopic asthma. The purpose of this study was to determine whether airway inflammation in heaves is associated with
a pattern of expression of cytokine suggestive of a Th2 type response. The expression of mRNA, encoding interleukin (IL)-4, IL-5,
and interferon gamma (IFN-
) was measured in bronchoalveolar
cells from seven horses with heaves and five control horses, using
in situ hybridization and radiolabeled equine-specific cRNA probes
coding for these cytokines. Bronchoalveolar cells of horses with
heaves had an increased expression of IL-4 (p = 0.01) and IL-5
(p = 0.02) mRNA and a decreased expression of INF-
(p = 0.01)
compared with control horses. Here we show that inflammatory
cells in lungs from horses with heaves display a Th2-type cytokine
profile that is consistent with the hypothesis that heaves is an allergic condition with similarity to human asthma.
| |
INTRODUCTION |
|---|
|
|
|---|
Keywords: neutrophils; Th2 cells; cytokines; asthma; inflammation
There is a general belief that asthma is a condition unique to humans. However, heaves is a common disease of horses that shares many features of human asthma, including lower airway inflammation, reversible airflow obstruction, and bronchial hyperresponsiveness (1). Heaves can be induced in susceptible horses by the inhalation of dust from moldy hay and the airway obstruction is reversible when horses are maintained on pasture (1, 4). Similar to asthma, heaves can be controlled by the administration of corticosteroids and bronchodilators. Heaves develops over a period of years and offers a unique model to study the respiratory system under chronic inflammatory conditions.
Extrinsic asthma is an allergic response to environmental allergens, and a similar immunologic mechanism may be implicated in heaves. The positive passive cutaneous anaphylaxis test observed using sera from horses with heaves (5) and the elevated levels of IgE in serum and bronchoalveolar lavage (BAL) of affected horses are supportive of the involvement of a type I hypersensitivity reaction in the airway response to exposure to moldy hay (6).
Th2-type lymphocytes, mast cells and eosinophils are considered the primary effector cells leading to allergic airway inflammation (9, 10). However, the individual roles of these cells and their mediators in events leading to the morphologic and functional changes of the asthmatic lung are uncertain (11). Heaves, unlike asthma, is characterized by a neutrophil recruitment into airway secretions after antigenic stimulation (12). There is also evidence that neutrophils may be implicated in some cases of asthma as blood neutrophils are activated and infiltrate the airway of chronic asthmatics, and indeed they have been reported to be the predominant cells in the airway secretions of patients with acute asthma (13).
The purpose of this study was to determine whether horses with heaves present a polarized cytokine expression in the bronchoalveolar (BAL) cells and to compare this cytokine profile with horses without respiratory disease. We reasoned that the study would shed light on the nature of the inflammatory process in the equine airway in heaves and that the results might have relevance to these subjects with asthma whose airway inflammation is predominantly neutrophilic. Another important feature of the study is that the changes found are a response to a prolonged exposure to the offending agents.
| |
METHODS |
|---|
|
|
|---|
All experimental procedures were performed in accordance with the guidelines of the Canadian Council for Animal Care and were approved by the Animal Care Committee of the Faculty of Veterinary Medicine of the Université de Montréal.
Horses
Twelve horses weighing 400 to 500 kg were used for the study. Horses with heaves (n = 7, 14.8 ± 0.9 yr of age, mean ± SEM) had a history of chronic respiratory diseases and abnormal respiratory mechanics measurements and a > 5% neutrophils in bronchoalveolar fluid (BAL). Control horses (n = 5, 9.6 ± 2.7 yr of age) had no history or clinical signs of respiratory diseases and had < 5% neutrophils in BAL. A physical examination and upper airway endoscopy were performed prior to the study to exclude the presence of concomitant medical conditions. The degree of respiratory distress of each horse was determined using a respiratory score based on a visual analog scale from 1 to 100 and related to the excursion of abdominal muscles and distension of the nostrils during quiet breathing.
Horses were fed with dry Timothy hay and sweet feed twice a day and bedded on straw. No changes had occurred in the environment of horses for > 3 mo prior to the study with the exception of one horse, which had been recruited only 3 wk before the study. No historic information was available for this latter horse. Animals were therefore exposed for a prolonged period ranging from at least 3 wk to 3 mo. No treatments were administered to horses for at least 3 wk prior to the study.
Bronchoalveolar Lavage
Bronchoalveolar lavages were performed under sedation using a fibroptic endoscope, as previously described (18). The BAL fluid was collected in siliconized glass vessels and kept on ice. It was then filtered through sterile gauze, centrifuged (1,500 rpm at 5° C for 5 min) and the cell pellets were resuspended in RPMI 1640 culture medium (Sigma-Aldrich Canada, Oakville, ON, Canada). BAL fluid was analyzed within 1 h of collection.
The total cell counts were determined on a fresh specimen of lavage fluid using a hemacytometer. The differential cell counts were determined on a cytospin slide that was prepared with a Cytospin model II (Shandon Southern Instruments, Sewickley, PA) and stained with a Wright Giemsa stain. At least 400 cells in each specimen were counted under oil-immersion microscopy.
Cytologic Preparations for Immunocytochemistry and in situ Hybridization
Cytospin slides were prepared on poly-L-lysine-coated glass slides,
fixed in 4% paraformaldehyde for 30 min, and washed with PBS (twice
for 5 min each time) prior to processing. In situ hybridization was performed as previously described (19, 20) using antisense and sense riboprobes prepared from cDNAs coding for equine IL-4, IL-5 mRNA
(pEQUIL4 and pEQUIL5zeo were kindly provided by Dr. Horohov,
Louisiana State University, Baton Rouge, LA), and IFN-
mRNA
(kindly provided by Dr. Antczak, Cornell University, Ithaca, NY).
Slides were coded, and positive cells were counted blindly using magnification ×40 with an eyepiece graticule. For negative controls cytospins were hybridized with sense probes or pretreated with RNase prior to the application of probes.
Data Analysis
Differences between groups were determined using the Mann-Whitney U test. Differences were considered significant when p values were less than 0.05. Data are expressed as means ± 1 SEM.
| |
RESULTS |
|---|
|
|
|---|
Horses
Horses with heaves had evidence of respiratory distress at the time of the study as indicated by the significant (p = 0.006) differences in respiratory scores in diseased horses (42 ± 9.2) and control horses (3.0 ± 3.0).
Bronchoalveolar Lavage Leukocytes
The total volume of BAL recovered was smaller in horses with heaves (median, 125 ml) than in control horses (median, 300 ml). There were no significant differences in total cell recovery in horses with heaves (median 2.6 × 106/ml) compared with control horses (median, 7.3 × 106/ml). Neutrophils predominated in BAL of horses with heaves, whereas lymphocytes and macrophages were the predominant cells in BAL from control horses (Figure 1).
|
Cytokine mRNA Expression
Positive hybridization for IL-4, IL-5, and IFN-
mRNA was
observed in the BAL cells of all horses. The number of cells
expressing IL-4 and IL-5 mRNA was significantly greater in
BAL cells of horses with heaves, whereas the number of cells
expressing IFN-
was greater in control horses (Figure 2). No
hybridization was present in the specimens that were incubated with sense probes or in the specimens that were pretreated with RNAse.
|
| |
DICUSSION |
|---|
|
|
|---|
The increased number of cells expressing mRNA for IL-4 and
IL-5 and a decreased expression of IFN-
in the present study
suggests that inflammatory cells in lungs of horses with heaves
display a predominant Th2-type cytokine profile. This finding
is in agreement with the hypothesis that heaves is an allergic
condition similar to that of human asthma. Although a polarization of T helper cells into predominantly Th1 and Th2 subsets has not been thoroughly investigated in horses, the finding of the present study is consistent with the Th2 cytokine
profile (increased expression of IL-4 mRNA and a decreased
expression IL-2 mRNA) observed with in vitro culture of equine
CD4+ T cells after chronic allergen stimulation (21). The
presence of cytokine mRNA in sufficient copy number to be detected by in situ hybridization provides evidence of gene expression, but it does not prove active synthesis of the relevant
protein. At the time of this writing, there were no monoclonal
antibodies available for quantitative measurement of the equine
IL-4, IL-5, and IFN-
production.
IL-4 promotes the development and the growth of Th2 cell
phenotype and is essential for the induction of B-cell isotype
switching to IgE antibody production (22). The increase in IL-4
mRNA expression in heaves is consistent with the elevated
levels of antigen-specific IgE in serum and BAL of horses with
heaves (6). The results of IL-5 mRNA expression in the
present study are less clear. An increased expression of IL-5
mRNA is usually associated with tissue eosinophil migration,
which is not a common feature in heaves. Eosinophil migration into lung tissue results from a complex sequence of cumulative events involving cytokines, including IL-5, chemokines, and various inflammatory molecules (23). The presence of IL-5 within the airway lumen may not be sufficient by itself to induce local eosinophilia, as suggested by the results of a study
in a murine model, showing that circulating but not local IL-5
results in pulmonary eosinophilia (24). It is also possible that
IL-5 mRNA expression may not have been associated with a
protein production in the present study, as it has occurred in
human bronchitis (25). The recent finding that horses with
heaves have a high level of NF-
B consisting mainly of truncated p65 homodimers, rather than classic p65-p50 heterodimers,
may contribute to the lack of BAL eosinophilia in heaves (26),
as loss of the p50 locus in knockout mice ablates the eosinophilic airway response (27). The importance of NF-
B p65 homodimers to equine eosinophil chemoattractant synthesis, however, remains to be determined. Clearly, further studies are required before the dissociation between IL-5 mRNA expression and tissue eosinophilia observed in heaves is understood.
When susceptible horses are exposed to moldy hay, a delay of 5 h is expected before the initiation of neutrophil recruitment in lung tissues and the appearance of clinical signs of heaves (12). This finding is reminiscent of the late allergic response (LAR) in asthmatic subjects after allergen challenge, which is characterized by recruitment, activation, and tissue infiltration of primarily eosinophils, but also neutrophils and lymphocytes (14, 28). Although a number of potent chemotactic mediators of neutrophils such IL-8 and leukotriene B4 may be present in airway secretions (28, 29), recent finding suggests that T lymphocytes play a key role in the modulation of the LAR and tissue neutrophilia. Little is known concerning the mechanistic relationship between T lymphocytes and neutrophils, but T-lymphocyte cytokines such as IL-13 and IL-17 may play a central role in the selective recruitment of neutrophils into the airways via the release of C-X-C chemokines by bronchial epithelial cells (30).
Airway obstruction in asthma is not completely reversible, presumably because of inflammation-induced structural changes of the airways (33). Although the pathophysiologic role of eosinophils in asthma is well documented, it has been suggested that neutrophils also contribute to airway remodeling and to development of nonreversible airway obstruction (34). In chronic asthmatics, neutrophils are activated and infiltrate the airways several hours after antigen challenge and neutrophils are the predominant inflammatory leukocytes in airway secretions during severe asthma (13, 35, 36). The finding that heaves and severe asthma share many structural changes such as epithelial detachment and regeneration, goblet cell hyperplasia, and hyperplasia of the bronchial smooth muscles, further supports a role of neutrophils in airway remodeling (33, 37, 38). Neutrophils are capable of releasing mediators such as elastase, free oxygen radicals, and leukotriene B4, which may cause exacerbation of obstructive airway disease via tissue damage and airway gland hypersecretion (32, 39). It is now clear that neutrophils also have the capacity to produce a number of inflammatory cytokines and chemokines that may contribute to the modulation of airway inflammation in asthma (40). Although there is support for a role for neutrophils in airway inflammation and hypersecretion in asthma, their exact contribution to the airway pathology is poorly understood.
The finding in the present study of a predominant Th2 cytokine profile in airway cells associated with airway neutrophilia, but not with eosinophilia, suggests that this animal model of asthma may be useful in the study of the mechanisms implicated in the regulation of allergen-induced neutrophil migration.
| |
Footnotes |
|---|
Correspondence and requests for reprints should be addressed to Dr. Jean-Pierre Lavoie, Faculté de Médecine Vétérinaire, Département de Sciences Cliniques, 3200 Sicotte, St-Hyacinthe, CP 5000, PQ, J2S 7C6 Canada. E-mail: Jean-Pierre.Lavoie{at}umontreal.ca
(Received in original form December 19, 2000 and accepted in revised form July 23, 2001).
Dr. Maghni is the recipient of a fellowship from the Medical Research Council of Canada.
Acknowledgments:
Supported by the Fonds du Centenaire of the Université de Montréal and by the
Groupe de Recherche en Médecine Equine du Québec.
| |
References |
|---|
|
|
|---|
1. Lowell F. Observations on heaves: an asthma-like syndrome in the horse. J Allergy 1964; 35: 322-330 .
2. Snapper JR. Large animal models of asthma. Am Rev Respir Dis 1986; 133: 351-352 [Medline].
3. Robinson NE, Derksen FJ, Olszewski MA, Buechner-Maxwell VA. The pathogenesis of chronic obstructive pulmonary disease of horses. Br Vet J 1995; 152: 283-306 .
4. Jean D, Vrins A, Lavoie JP. Monthly, daily, and circadian variations of measurements of pulmonary mechanics in horses with chronic obstructive pulmonary disease. Am J Vet Res 1999; 60: 1341-1346 [Medline].
5. Eyre P. Equine pulmonary emphysema: a bronchopulmonary mould allergy. Vet Rec 1972; 91: 134-140 [Medline].
6. Halliwell REW, McGorum BC, Irving P, Dixon PM. Local and systemic antibody production in horses affected with chronic obstructive pulmonary disease. Vet Immunol Immunopathol 1993; 38: 201-215 [Medline].
7. Schmallenbach KH, Rahman I, Sasse HHL, Dixon PM, Halliwell REW, McGorum BC, Crameri R, Miller HRP. Studies on pulmonary and systemic Aspergillus fumigatus-specific IgE and IgG antibodies in horses affected with chronic obstructive pulmonary disease (COPD). Vet Immunol Immunopathol 1998; 66: 245-256 [Medline].
8. Eder C, Crameri R, Mayer C, Eicher R, Straub R, Gerber H, Lazary S, Marti E. Allergen-specific IgE levels against crude mould and storage mite extracts and recombinant mould allergens in sera from horses affected with chronic bronchitis. Vet Immunol Immunopathol 2000; 73: 241-253 [Medline].
9. Robinson DS, Hamid Q, Ying S, Tsicopoulos A, Barkans J, Bentley AM, Corrigan C, Durham SR, Kay AB. Predominant Th2-like bronchoalveolar T-lymphocyte population in atopic asthma. N Engl J Med 1992; 326: 298-394 [Abstract].
10. Ying S, Durham SR, Corrigan CJ, Hamid Q, Kay AB. Phenotype of cells expressing mRNA for TH2-type (interleukin 4 and interleukin 5) and TH1-type (interleukin 2 and interferon gamma) cytokines in bronchoalveolar lavage and bronchial biopsies from atopic asthmatic and normal control subjects. Am J Respir Cell Mol Biol 1995; 12: 477-487 [Abstract].
11. Hogan SP, Mould AW, Young JM, Rothenberg ME, Ramsay AJ, Matthaei K, Young IG, Foster PS. Cellular and molecular regulation of eosinophil trafficking to the lung. Immunol Cell Biol 1998; 76: 454-460 [Medline].
12. Fairbairn SM, Page CP, Lees P, Cunningham FM. Early neutrophil but not eosinophil or platelet recruitment to the lungs of allergic horses following antigen exposure. Clin Exp Allergy 1993; 23: 821-828 [Medline].
13. Diaz P, Gonzalez MC, Galleguillos FR, Ancic P, Cromwell O, Shepherd D, Durham SR, Gleich GJ, Kay AB. Leukocytes and mediators in bronchoalveolar lavage during allergen-induced late-phase asthmatic reactions. Am Rev Respir Dis 1989; 139: 1383-1389 [Medline].
14. Asman B, Strand V, Bylin G, Bergstrom K. Peripheral neutrophils after allergic asthmatic reactions. Int J Clin Lab Res 1997; 27: 185-188 [Medline].
15. Sur S, Crotty TB, Kephart GM, Hyma BA, Colby TV, Reed CE, Hunt LW, Gleich GJ. Sudden-onset fatal asthma. A distinct entity with few eosinophils and relatively more neutrophils in the airway submucosa? Am Rev Respir Dis 1993; 148: 713-719 [Medline].
16.
Lamblin C,
Gosset P,
Tillie-Leblond I,
Saulnier F,
Marquette CH,
Wallaert B,
Tonnel AB.
Bronchial neutrophilia in patients with noninfectious status asthmaticus.
Am J Respir Crit Care Med
1998;
157:
394-402
17.
Norzila MZ,
Fakes K,
Henry RL,
Simpson J,
Gibson PG.
Interleukin-8
secretion and neutrophil recruitment accompanies induced sputum
eosinophil activation in children with acute asthma.
Am J Respir Crit
Care Med
2000;
161:
769-774
18. Lapointe JM, Lavoie JP, Vrins AA. Effects of triamcinolone acetonide on pulmonary function and bronchoalveolar lavage cytologic features in horses with chronic obstructive pulmonary disease. Am J Vet Res 1993; 54: 1310-1316 [Medline].
19.
Kay AB,
Ying S,
Varney V,
Gaga M,
Durham SR,
Moqbel R,
Wardlaw AJ,
Hamid Q.
Messenger mRNA expression of the cytokine gene
cluster, interleukin 3 (IL-3), IL-4, IL-5 and granulocyte/macrophage
colony-stimulating factor, in allergen-induced late-phase cutaneous
response in atopic subjects.
J Exp Med
1991;
173:
775-778
20. Watanabe A, Mishima H, Kotsimbos TC, Hojo M, Renzi PM, Martin JG, Hamid QA. Adoptively transferred late allergic responses are associated with Th2-type cytokines in the rat. Am J Respir Cell Mol Biol 1997; 16: 69-74 [Abstract].
21. Aggarwal N, Holmes MA. Characterisation of equine T helper cells: demonstration of Th1- and Th2-like cells in long-term equine T-cell cultures. Res Vet Sci 1999; 66: 277-279 [Medline].
22. Lasky JA, Brody AR. Interleukins involved in the pathogenesis of chronic airway inflammation. Res Immunol 1997; 148: 39-47 [Medline].
23. Wardlaw AJ. Molecular basis for selective eosinophil trafficking in asthma: a multistep paradigm. J Allergy Clin Immunol 1999; 104: 917-926 [Medline].
24. Wang J, Palmer K, Lotvall J, Milan S, Lei XF, Matthaei KI, Gauldie J, Inman MD, Jordana M, Xing Z. Circulating, but not local lung, IL-5 is required for the development of antigen-induced airways eosinophilia. J Clin Invest 1998; 102: 1132-1141 [Medline].
25. Jeffery PK. Differences and similarities between chronic obstructive pulmonary disease and asthma. Clin Exp Allergy 1999;29(Suppl 2:14-26).
26.
Bureau F,
Bonzini G,
Kirschvink N,
Delhalle S,
Desmecht D,
Merville MP,
Bours V,
Lekeux P.
Correlation between nuclear factor-kappa B
activity in bronchial brushing samples and lung destruction in an animal model of asthma.
Am J Respir Crit Care Med
2000;
161:
1314-1321
27.
Yang L,
Cohn L,
Zhang DH,
Homer R,
Ray A,
Ray P.
Essential role of
nuclear factor kappaB in the induction of eosinophilia in allergic airway inflammation.
J Exp Med
1998;
188:
1739-1750
28. Nocker RE, Out TA, Weller FR, Mul EP, Jansen HM, van der Zee JS. Influx of neutrophils into the airway lumen at 4 h after segmental allergen challenge in asthma. Int Arch Allergy Immunol 1999; 119: 45-53 [Medline].
29. Pearlman DS. Pathophysiology of the inflammatory response. J Allergy Clin Immunol 1999; 104: S132-S137 [Medline].
30.
Shim JJ,
Dabbagh K,
Ueki IF,
Dao-Pick T,
Burgel PR,
Takeyama K,
Tam DC,
Nadel JA.
IL-13 induces mucin production by stimulating
epidermal growth factor receptors and by activating neutrophils.
Am J
Physiol Lung Cell Mol Physiol
2001;
280:
L134-140
31.
Laan M,
Cui ZH,
Hoshino H,
Lotvall J,
Sjostrand M,
Gruenert DC,
Skoogh BE,
Linden A.
Neutrophil recruitment by human IL-17 via
C-X-C chemokine release in the airways.
J Immunol
1999;
162:
2347-2352
32. Linden A, Hoshino H, Laan M. Airway neutrophils and interleukin-17. Eur Respir J 2000; 15: 973-977 [Abstract].
33. Molet S, Hamid Q. Role of airway remodeling in severe asthma. In: Szefler SJ, Leung DY, editors. Severe Asthma, 2nd ed. New York: Marcel Dekker; 2001. p. 89-124.
34.
Wenzel SE,
Schwartz LB,
Langmack EL,
Halliday JL,
Trudeau JB,
Gibbs RL,
Chu HW.
Evidence that severe asthma can be divided pathologically into two inflammatory subtypes with distinct physiologic and clinical characteristics.
Am J Respir Crit Care Med
1999;
160:
1001-1008
35. Monteseirin J, Camacho MJ, Gutierrez D, Llamas E, Guardia P, Bonilla I, Sanchez-Monteseirin H, Conde J. Neutrophils and allergy. Allergol Immunopathol (Madr) 1996; 24: 193-200 [Medline].
36.
Ordonez CL,
Shaughnessy TE,
Matthay MA,
Fahy JV.
Increased neutrophil numbers and IL-8 levels in airway secretions in acute severe
asthma: clinical and biologic significance.
Am J Respir Crit Care Med
2000;
161:
1185-1190
37. Kaup F-J, Drommer W, Damsch S, Deegen E. Ultrastructural findings in horses with chronic obstructive pulmonary disease (COPD) 2: pathological changes of the terminal airways and the alveolar region. Equine Vet J 1990; 22: 349-355 [Medline].
38. Robinson NE. International workshop on equine chronic airway disease. Equine Vet J 2001; 33: 5-19 [Medline].
39. Weiss SJ. Tissue destruction by neutrophils. N Engl J Med 1989; 320: 365-376 [Medline].
40. Cassatella MA, Gasperini S, Russo MP. Cytokine expression and release by neutrophils. Ann N Y Acad Sci 1997; 832: 233-242 [Medline].
This article has been cited by other articles:
![]() |
I. C. Allen Searching for an improved mouse model of allergic airway disease using dual allergen exposures Dis. Model. Mech., November 1, 2009; 2(11-12): 519 - 520. [Full Text] [PDF] |
||||
![]() |
H. Huang, A. Lavoie-Lamoureux, K. Moran, and J.-P. Lavoie IL-4 stimulates the expression of CXCL-8, E-selectin, VEGF, and inducible nitric oxide synthase mRNA by equine pulmonary artery endothelial cells Am J Physiol Lung Cell Mol Physiol, May 1, 2007; 292(5): L1147 - L1154. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. D. Fixman, A. Stewart, and J. G. Martin Basic mechanisms of development of airway structural changes in asthma Eur. Respir. J., February 1, 2007; 29(2): 379 - 389. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. S. Davis, J. R. Malayer, L. Vandeventer, C. M. Royer, E. C. McKenzie, and K. K. Williamson Cold weather exercise and airway cytokine expression J Appl Physiol, June 1, 2005; 98(6): 2132 - 2136. [Abstract] [Full Text] [PDF] |
||||
![]() |
M G Kelly, J S Elborn, M G Kelly, V Brown, M Ennis, and F Bureau Measuring granulocyte apoptosis in airway inflammation Thorax, April 1, 2002; 57(4): 376 - 376. [Full Text] [PDF] |
||||
![]() |
M. J. TOBIN Asthma, Airway Biology, and Nasal Disorders in AJRCCM 2001 Am. J. Respir. Crit. Care Med., March 1, 2002; 165(5): 598 - 618. [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Proc. Am. Thorac. Soc. | Am. J. Respir. Cell Mol. Biol. |